english.prescrire.org > Spotlight > Archives : 2008 > Fentanyl by iontophoresis

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2008 : 1 | 30 | 60

Fentanyl by iontophoresis

FEATURED REVIEW A transdermal system for fentanyl, an opiate analgesic, will soon be marketed in France for patient-controlled relief of acute postoperative pain by iontophoresis, a needle-free technique. This system not particularly convenient and there is a risk of misuse and overdose.
Full review (4p) in English available for download by subscribers.

- Click here for full review (subscribers only).

Abstract

  • A transdermal system for fentanyl, an opiate analgesic, will soon be marketed in France for patient-controlled relief of acute postoperative pain. Pushing a button delivers a dose of fentanyl (contained in a reservoir) into the general circulation by the transdermal route, by means of iontophoresis, a needle-free technique.
  • The European Medicines Agency only took into account one comparative trial. This unblinded study failed to show that the efficacy of transdermal fentanyl delivered by means of iontophoresis is equal to that of intravenous morphine for patient-controlled analgesia.
  • The adverse effects of transdermal fentanyl are those of all opiates, plus cutaneous reactions at the application site.
  • This transdermal system is not particularly convenient: the device is no simpler for patients to use than a pump for intravenous administration. There is also a risk of misuse and overdose: the number of doses per push cannot be verified, there is no lockout period between two button pushes, special precautions must be taken when washing, and the used devices still contain fentanyl.